Intestinal organ chips for disease modelling and personalized medicine

A Özkan, NT LoGrande, JF Feitor, G Goyal… - Nature Reviews …, 2024 - nature.com
Alterations in intestinal structure, mechanics and physiology underlie acute and chronic
intestinal conditions, many of which are influenced by dysregulation of microbiome …

Realizing the promise of project optimus: challenges and emerging opportunities for dose optimization in oncology drug development

W Gao, J Liu, B Shtylla… - CPT …, 2024 - Wiley Online Library
Project Optimus is a US Food and Drug Administration Oncology Center of Excellence
initiative aimed at reforming the dose selection and optimization paradigm in oncology drug …

Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges

O Irrechukwu, R Yeager, R David, J Ekert… - ALTEX-Alternatives to …, 2023 - altex.org
Disease models enable researchers to investigate, test, and identify therapeutic targets that
would alter the patients' disease condition and improve quality of life. Advances in genetic …

Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D in vitro tissue models of disease

JL Cadavid, NT Li, AP McGuigan - Biophysics Reviews, 2024 - pubs.aip.org
Rapid advances in tissue engineering have resulted in more complex and physiologically
relevant 3D in vitro tissue models with applications in fundamental biology and therapeutic …

[HTML][HTML] How to build a tumor: An industry perspective

J Schueler, J Borenstein, L Buti, M Dong… - Drug Discovery …, 2022 - Elsevier
During the past 15 years, a plethora of innovative 3D in vitro systems has been developed.
They offer the possibility of identifying crucial cellular and molecular contributors to the …

Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends

SL Song, B Li, MR Carvalho, HJ Wang, DL Mao… - Pharmacology & …, 2022 - Elsevier
Digestive system cancers account for nearly half of all cancers around the world and have a
high mortality rate. Cell culture and animal models represent cornerstones of digestive …

[HTML][HTML] Modelling the Tumour Microenvironment, but What Exactly Do We Mean by “Model”?

CC Reyes-Aldasoro - Cancers, 2023 - mdpi.com
Simple Summary The word “model” can be used with different meanings and different
contexts, like a model student, clay models or a model railway. In some cases, the context …

Opportunities for Microphysiological Systems from the View of Japanese Industries

H Naraoka, T Iguchi, K Harada, T Usui, Y Suwa… - Drug Metabolism and …, 2024 - Elsevier
Regulatory authorities and pharmaceutical companies in Europe and the United States have
paid attention to microphysiological systems (MPS), and various consortia and academic …

[HTML][HTML] Two-step global sensitivity analysis of a non-local integro-differential model for Cancer-on-Chip experiments

E Campanile, A Colombi, G Bretti - Mathematical Biosciences, 2024 - Elsevier
The present work focuses on a non-local integro-differential model reproducing Cancer-on-
chip experiments where tumor cells, treated with chemotherapy drugs, secrete chemical …

Model-informed decision making in the preclinical stages of pharmaceutical research and development

R Li, M Craig, DZ D'Argenio, A Betts… - Frontiers in …, 2023 - frontiersin.org
in real-world drug research, and, in turn, facilitate insight and guidance for future research in
quantitative pharmacological modeling and simulation. Presented as a high-level overview …